HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study.

Bayram, Nazende Nur; Ulu, Gizem Tugçe; Abdulhadi, Nusaibah Abdulsalam; Gürdap, Seda; Isoglu, Ismail Alper; Baran, Yusuf; Isoglu, Sevil Dinçer

Bayram, Nazende Nur; Ulu, Gizem Tugçe; Abdulhadi, Nusaibah Abdulsalam; Gürdap, Seda; Isoglu, Ismail Alper; Baran, Yusuf; Isoglu, Sevil Dinçer.

Afiliação

Bayram NN; Department of Bioengineering, Faculty of Life and Natural Sciences, Abdullah Gül University, 38080 Kayseri, Turkey.
Ulu GT; Molecular Biology and Genetics, Faculty of Science, Izmir Institute of Technology, 35433 Izmir, Turkey.
Abdulhadi NA; Molecular Biology and Genetics, Faculty of Science, Izmir Institute of Technology, 35433 Izmir, Turkey.
Gürdap S; Department of Bioengineering, Faculty of Life and Natural Sciences, Abdullah Gül University, 38080 Kayseri, Turkey.
Isoglu IA; Department of Bioengineering, Faculty of Life and Natural Sciences, Abdullah Gül University, 38080 Kayseri, Turkey.
Baran Y; Molecular Biology and Genetics, Faculty of Science, Izmir Institute of Technology, 35433 Izmir, Turkey.
Isoglu SD; Department of Bioengineering, Faculty of Life and Natural Sciences, Abdullah Gül University, 38080 Kayseri, Turkey.

Pharmaceutics ; 15(3)2023 Feb 22.

Article em En | MEDLINE | ID: mdl-36986594

Palavras-chave

HER2; breast cancer; human epidermal growth factor receptor 2 targeting; stable micelles; the antitumor effect

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google